(Q37401088)

20 August 2017

1 reference

title

Lichenoid tissue reaction/interface dermatitis: clinical and histological perspectives (English)

1 reference

20 August 2017

Richard D Sontheimer

1

1 reference

20 August 2017

language of work or name

English

0 references

publication date

26 February 2009

1 reference

Journal of Investigative Dermatology

20 August 2017

published in

1 reference

20 August 2017

volume

129

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

1088-1099

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2009.42

20 August 2017

exact match

0 references

cites work

Resolvins and protectins in the termination program of acute inflammation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Interleukin-18 gene polymorphisms and haplotypes in patients with oral lichen planus: a study in an ethnic Chinese cohort

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Significance of liquefaction degeneration in oral lichen planus: a study of its relationship with apoptosis and cell cycle arrest markers

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Heat shock proteins 60 and 70 expression of cutaneous lichen planus: comparison with normal skin and psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Ultraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Lichenoid dermatoses and related disorders. I. Lichen planus and lichenoid drug-induced eruptions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Apoptosis in physiological and pathological skin: implications for therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Lichen planus responding to efalizumab

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

The frequency of different T-cell receptor V-families in oral lichen planus and lichenoid contact lesions: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Oral erosive lichen planus treated with efalizumab

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Treatment of refractory subacute cutaneous lupus erythematosus with efalizumab.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Idiopathic perniosis and its mimics: a clinical and histological study of 38 cases

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Immunohistochemical analysis of regulatory T cell markers FOXP3 and GITR on CD4+CD25+ T cells in normal skin and inflammatory dermatoses

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Lichen planus, lichenoid drug reactions, and lichenoid mucositis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Design and optimization of imidazole derivatives as potent CXCR3 antagonists

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

New histopathologic findings in drug eruptions.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Langerin-expressing and CD83-expressing cells in oral lichen planus lesions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Treatment of recalcitrant dermatomyositis with efalizumab

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Toxic shock syndrome or toxic epidermal necrolysis? Case reports showing clinical similarity and histologic separation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

New concepts in antimalarial use and mode of action in dermatology

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Survival signalling in keratinocytes of erythematous oral lichen planus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Inhibition of the transforming growth factor-beta/Smad signaling pathway in the epithelium of oral lichen.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

The role of perforin-mediated apoptosis in lichen planus lesions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

“Endogenous adjuvant” activity of the RNA components of lupus autoantigens Sm/RNP and Ro 60

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

In vivo adjuvant activity of the RNA component of the Sm/RNP lupus autoantigen

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Development of CXCR3 antagonists. Part 4: discovery of 2-amino-(4-tropinyl)quinolines

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Apoptosis and necrosis: detection, discrimination and phagocytosis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Chronic inflammation: a failure of resolution?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonists

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Blockade of chemokine receptor CXCR3 inhibits T cell recruitment to inflamed joints and decreases the severity of adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Human keratinocytes maintain reversible anti-apoptotic defenses in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Perforin expression in peripheral blood lymphocytes and skin-infiltrating cells in patients with lichen planus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Unusual variant of lupus erythematosus or lichen planus. Clinical, histopathologic, and immunofluorescent studies

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Cytotoxic molecule expression and epithelial cell apoptosis in oral and cutaneous lichen planus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Recruitment of dendritic cells in oral lichen planus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

The role of granzyme B-expressing CD8-positive T cells in apoptosis of keratinocytes in lichen planus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

The immunological basis of lichenoid tissue reaction

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Lichenoid tissue reaction induced by local transfer of Ia-reactive T-cell clones. III. Role of Ia+ keratinocytes in the epidermotropic migration of the T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Induction and control of lichenoid tissue reactions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Immunopathologic study of lichenoid skin diseases: correlation between HLA-DR-positive keratinocytes or Langerhans cells and epidermotropic T cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Lichenoid tissue reaction induced by local transfer of Ia-reactive T-cell clones

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

In vivo effects of interferon-gamma and anti-interferon-gamma antibody on the experimentally induced lichenoid tissue reaction

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Epidermal Langerhans cell involvement in cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Immunologically mediated epidermal cell injury

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

The pathogenesis of oral lichen planus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Spontaneous tolerance to terbinafine-induced lichenoid drug eruption

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Lichenoid eruptions in children

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Targeting of Th1-associated chemokine receptors CXCR3 and CCR5 as therapeutic strategy for inflammatory diseases

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Efalizumab in the treatment of discoid lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

NADPH oxidases: new players in TNF-induced necrotic cell death

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Inflammation suppressor genes: please switch out all the lights

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Evidence for a role of type I interferons in the pathogenesis of dermatomyositis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Type I interferon-associated cytotoxic inflammation in lichen planus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.42

7 January 2021

Identifiers

DOI

10.1038/JID.2009.42

1 reference

Dimensions Publication ID

20 August 2017

1016293387

0 references

1 reference